Objective: To detect potential variation in glutaryl-CoA dehydrogenase (GCDH) gene among three Chinese families affected with glutaric acidemia type Ⅰ(GA-1) and correlate the genotypes with phenotypes.

Methods: Genomic DNA was extracted from peripheral blood samples derived from three patients with GA-1 and their family members. The coding regions of the GCDH gene were amplified with PCR and subjected to Sanger sequencing.

Results: The clinical manifestation of the patients varied from macrocephaly to severe encephalopathy, with notable phenotypic difference between siblings carrying the same variation. In pedigrees 1 and 2, the probands have carried compound heterozygous variations c.1133C>T(p.Ala378Val) and c.1244-2A>C, which were derived their fathers and mothers, respectively. In pedigree 3, the proband has carried compound heterozygous variation c.339delT (p.Tyr113) and c.406G>T (p.Gly136Cys). Among these, variations c.339delT and c.1133C>T were verified as novel by retrieval of dsSNP, HGMD and 1000 genome database. Bioinformatic analysis suggested that above variations can affect protein function and are probably pathogenic.

Conclusion: Above discovery has expanded the mutation spectrum of the GCDH gene. No correlation was found between the clinical phenotype and genotype of GA-1 patients.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.1003-9406.2018.06.004DOI Listing

Publication Analysis

Top Keywords

gcdh gene
12
three chinese
8
chinese families
8
families glutaric
8
glutaric acidemia
8
acidemia type
8
carried compound
8
compound heterozygous
8
[clinical variation
4
variation analysis
4

Similar Publications

Background: Meat quality in yak is influenced by the fluctuation of nutritional composition in different grazing seasons on the Qinghai-Tibetan Plateau. However, the molecular mechanism underlying in yak meat remains unknown. Therefore, this study aimed to investigate the seasonal dynamics of meat quality in yak by transcriptomics and metabolomics techniques.

View Article and Find Full Text PDF

To determine the disease spectrum and genetic characteristics of inborn errors of metabolism (IEM) in Xinjiang province in the northwest of China, 41,690 newborn babies were screening by tandem mass spectrometry from November 2018 to December 2021. Of these, 57 newborn babies were referred for genetic analysis by next-generation sequencing, which was validated by Sanger sequencing. A total of 36 newborn babies and one relative were diagnosed with IEM, and the overall positive predictive value was 29.

View Article and Find Full Text PDF
Article Synopsis
  • Elevated fetal hemoglobin (HbF) can reduce disease severity in β hemoglobinopathies, and understanding its genetic basis may lead to personalized treatments.
  • A systematic review of GWAS studies identified 939 significant SNP-trait associations linked to HbF, focusing on genes primarily located on chromosomes 2, 6, and 11, among others.
  • The study emphasizes the need for further research on less frequently associated genetic loci and suggests a focus on diverse populations to improve therapeutic strategies for conditions like sickle cell disease and β-thalassemia.
View Article and Find Full Text PDF

Rewiring Lysine Catabolism in Cancer Leads to Increased Histone Crotonylation and Immune Escape.

Chembiochem

December 2024

Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, David De Wied building, Universiteitsweg 99, 3584 CG, Utrecht, NL.

Crotonyl-CoA (cr-CoA) is a metabolite derived directly from the catabolism of lysine (Lys) and tryptophan (Trp) or from the β-oxidation of fatty acids. In glioblastoma stem cells (GSCs), histone H4 crotonylation levels are significantly elevated, which appears to positively correlate with tumor growth. This increase in crotonyl-CoA production is attributed to the overexpression of specific Lys transporters on the cell membrane, leading to higher free lysine levels.

View Article and Find Full Text PDF
Article Synopsis
  • - Glutaric aciduria type 1 (GA1) is a genetic disorder caused by a deficiency in the enzyme glutaryl-CoA dehydrogenase (GCDH), leading to the buildup of harmful organic acids that impair brain function and can result in severe neurological symptoms.
  • - A case of a six-month-old boy with GA1 showed that he experienced seizures after a fever, underwent various treatments including non-invasive ventilation, and was diagnosed via brain MRI and specialized tests, but unfortunately did not survive despite timely medical intervention.
  • - Effective management of GA1 focuses on dietary changes, such as a low-lysine diet and the use of carnitine, highlighting the critical importance of early detection through newborn screening to
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!